SCHEMBL31435232

SCHEMBL31435232

COc1cc(-c2nc(CN3CCC(C(=O)Nc4cccc(C(F)(F)F)c4)CC3C)no2)ccc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
LMNA P02545 5/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
MAPT P10636 4/20 0.44
TSHR P16473 2/20 0.44
MAPK1 P28482 1/20 0.44
UBE2M P61081 3/20 0.44
DCUN1D1 Q96GG9 3/20 0.44
ALDH1A1 P00352 1/20 0.43
ACKR3 P25106 3/20 0.43
KDM4E B2RXH2 2/20 0.42
USP2 O75604 2/20 0.41
HTT P42858 2/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TP53 P04637 2/20 0.41
ADORA2B P29275 3/20 0.41
ADORA2A P29274 2/20 0.41
ADORA1 P30542 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31435222 0.91 UBE2M (0.46) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL31435225 0.91 UBE2M (0.46) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL31435231 0.91 UBE2M (0.46) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL31435221 0.89 UBE2M (0.50) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL31435236 0.84 UBE2M (0.43) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL31435245 0.82 UBE2M (0.45) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL31435233 0.82 ACKR3 (0.38) MEN1KMT2ALMNASMN1; SMN2TSHR
SCHEMBL31435252 0.82 ACKR3 (0.38) MEN1KMT2ALMNASMN1; SMN2TSHR
SCHEMBL31435260 0.81 UBE2M (0.43) MEN1KMT2ALMNASMN1; SMN2MAPT
SCHEMBL31435244 0.81 UBE2M (0.43) MEN1KMT2ALMNASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025090928-A1 COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES AQUINNAH PHARMACEUTICALS, INC. (US) 2025-05-01 WO claimed
WO-2025090928-A1 COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES AQUINNAH PHARMACEUTICALS, INC. (US) 2025-05-01 WO disclosed